Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BGC20-1531 in PGE2-induced headache model
NCT00957983Phase 2Completed
- Sponsor
- Dansk Hovedpinecenter
- Start
- Aug 2009
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of BGC20-1531 in migraine, sponsored by Dansk Hovedpinecenter. Started Aug 2009; status: completed.
02
Drugs
BGC20-1531
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00957983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00957983.